Compare CLGN & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
Current Price
| Metric | CLGN | SLAI |
|---|---|---|
| Founded | 2004 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 15.5M |
| IPO Year | 2015 | N/A |
| Metric | CLGN | SLAI |
|---|---|---|
| Price | $0.43 | $0.86 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 149.1K | 129.8K |
| Earning Date | 05-27-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $240.45 | $8.65 |
| Revenue Next Year | $38.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $0.63 |
| 52 Week High | $4.98 | $2.55 |
| Indicator | CLGN | SLAI |
|---|---|---|
| Relative Strength Index (RSI) | 48.11 | 54.26 |
| Support Level | $0.27 | $0.81 |
| Resistance Level | $0.46 | $0.98 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 83.59 | 62.19 |
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.